Drugs / TIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01209780 | Sep 2010 → Mar 2011 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01209780 ↗ |
| Modality | Vaccine | “Investigational egg-derived trivalent subunit influenza vaccine.” NCT01209780 ↗ |
| Route | Intramuscular | “one or two IM dose(s) of trivalent subunit inactivated flu vaccine” NCT01209780 ↗ |